Jay S. Raval

Also affiliated with University of North Carolina at Chapel Hill, University of New Mexico, University of Vermont Medical Center

MedicineImmunology and MicrobiologyBusiness, Management and Accounting

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma”.

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

medRxiv(2021)10.1101/2021.12.10.21267485

N/A

1.4DataRank · unranked

38 citations

Kelly A. Gebo, Shmuel Shoham, Evan M. Bloch, Bryan Lau, Aarthi Shenoy +53 more

Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19

CHEST Journal(2022)10.1016/j.chest.2022.06.029

N/A

1.4DataRank · unranked

30 citations

Allison P. Wheeler, Thomas G. Stewart, Harry Schrager, Jason Mallada, Christopher B. Thomas +46 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

JCI Insight(2024)10.1172/jci.insight.178460

N/A

0.427DataRank · unranked

12 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial

Microbiology Spectrum(2023)10.1128/spectrum.03286-23

N/A

0.373DataRank · unranked

11 citations

Xianming Zhu, Andrew D. Redd, Kelly A. Gebo, Alison G. Abraham, Eshan U. Patel +42 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

medRxiv(2023)10.1101/2023.04.13.23288353

N/A

0.104DataRank · unranked

1 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

Transfusion(2023)10.1111/trf.17485

N/A

0DataRank · unranked

11 citations

Jay S. Raval, James H. Paxton, Giselle Mosnaim, Bela Patel, Shweta Anjan +53 more

A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry

Blood Advances(2023)10.1182/bloodadvances.2023010807

N/A

0DataRank · unranked

7 citations

Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland +26 more

Early Treatment, Inflammation and Post-COVID Conditions

medRxiv(2023)10.1101/2023.02.13.23285855

N/A

0DataRank · unranked

5 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Alison G. Abraham +38 more

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102388

N/A

0DataRank · unranked

6 citations

Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland +26 more

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era

Blood Advances(2024)10.1182/bloodadvances.2024013313

N/A

0DataRank · unranked

4 citations

Michael D. Evans, Jenna Brown, Elizabeth E. Davis, Andrew D. Johnson, Ana G. Antun +27 more

Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction Syndrome

Journal of Clinical Apheresis(2024)10.1002/jca.22147

N/A

0DataRank · unranked

2 citations

Jay S. Raval, Jan Hofmann, Joseph A. Carcillo, Matthew J. Foglia

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.642

N/A

0DataRank · unranked

1 citations

Christi E. Marshall, David E. Reichert, Aaron Ye, P Khanal, Sanford H. Robbins +57 more

Rainbow of hemolysis associated with acquired thrombotic thrombocytopenic purpura

UNC Libraries(2024)10.17615/97q6-cz21

N/A

0DataRank · unranked

0 citations

Jay S. Raval, Marshall Mazepa, Raj S. Kasthuri, Yara A. Park, Herbert C. Whinna +2 more

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

UNC Libraries(2024)10.17615/djvv-pg14

N/A

0DataRank · unranked

0 citations

Harsh Vardhan Upreti, X. Long Zheng, Jay S. Raval, Raj S. Kasthuri, Spero R. Cataland +27 more

Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era

UNC Libraries(2024)10.17615/pf72-y335

N/A

0DataRank · unranked

0 citations

Camila Masias, Michael D. Evans, Shruti Chaturvedi, Ryan Woods, Yara A. Park +28 more

Race, rituximab, and relapse in TTP

Blood(2022)10.1182/blood.2022016640

N/A

0DataRank · unranked

41 citations

Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park +24 more

How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?

Transfusion(2022)10.1111/trf.16871

N/A

0DataRank · unranked

20 citations

Aaron A.R. Tobian, Shmuel Shoham, Daniel F. Hanley, Thomas J. Gniadek, Edward R. Cachay +32 more

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

The Lancet Microbe(2023)10.1016/s2666-5247(23)00171-4

N/A

0DataRank · unranked

77 citations

Kelly A. Gebo, Alison G. Abraham, Feben Habtehyimer, Eshan U. Patel, Oliver Laeyendecker +43 more

Early antibody treatment, inflammation, and risk of post-COVID conditions

mBio(2023)10.1128/mbio.00618-23

N/A

0DataRank · unranked

22 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Allison G. Abraham +38 more